SCV
Sands Capital Ventures Portfolio holdings
AUM
$508M
This Quarter Return
-1.68%
1 Year Return
+48.12%
3 Year Return
+324.3%
5 Year Return
–
10 Year Return
–
AUM
$663M
AUM Growth
–
Cap. Flow
+$663M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
98.34%
Holding
13
New
13
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
UiPath
PATH
|
$201M |
| 2 |
DoorDash
DASH
|
$130M |
| 3 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$103M |
| 4 |
Snowflake
SNOW
|
$95.7M |
| 5 |
Acumen Pharmaceuticals
ABOS
|
$50.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 44.67% |
| 2 | Healthcare | 35.75% |
| 3 | Consumer Discretionary | 19.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$5.95B
| $201M | 30.24% |
+3,811,779
| New | +$201M |
|
|
2
DoorDash
DASH
$105B
| $130M | 19.57% |
+630,217
| New | +$130M |
|
|
DICE
3
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $103M | 15.55% |
+3,148,970
| New | +$103M |
|
|
4
Snowflake
SNOW
$79.6B
| $95.7M | 14.44% |
+316,576
| New | +$95.7M |
|
|
5
Acumen Pharmaceuticals
ABOS
$82.4M
| $50.8M | 7.66% |
+3,417,075
| New | +$50.8M |
|
|
KRTX
6
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $32.8M | 4.94% |
+267,895
| New | +$32.8M |
|
7
Taysha Gene Therapies
TSHA
$797M
| $13.5M | 2.04% |
+724,873
| New | +$13.5M |
|
8
908 Devices
MASS
$226M
| $10.6M | 1.6% |
+326,427
| New | +$10.6M |
|
9
Candel Therapeutics
CADL
$318M
| $8.8M | 1.33% |
+811,737
| New | +$8.8M |
|
10
Repligen
RGEN
$6.88B
| $6.52M | 0.98% |
+22,544
| New | +$6.52M |
|
11
Tarsus Pharmaceuticals
TARS
$2.47B
| $5.6M | 0.84% |
+260,000
| New | +$5.6M |
|
|
SPRB
12
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $4.73M | 0.71% |
+787,007
| New | +$4.73M |
|
13
Absci
ABSI
$357M
| $672K | 0.1% |
+57,804
| New | +$672K |
|